Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829331 · ClinicalTrials.gov registry record · NA
Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site
A NA study, sponsored by Acera Surgical.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04829331: Clinical Trial NA study, sponsored by Acera Surgical.
NCT04829331 is a NA study that was terminated before completion, run by Acera Surgical. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04829331, a NA study, was terminated before completion, sponsored by Acera Surgical.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Understand association between use of Restrata (Acera Surgical Inc., St. Louis, MO) in forearm flap reconstruction with donor site healing and function
Primary Outcome
Percentage of participants with tendon exposure
Interventions
- DEVICE Restrata
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
Why NCT04829331 stopped before completion
NCT04829331 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Restrata is the first listed.
NCT04829331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04829331 about?
NCT04829331 is a clinical study titled "Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site". Understand association between use of Restrata (Acera Surgical Inc., St. Louis, MO) in forearm flap reconstruction with donor site healing and function
What is the current status of trial NCT04829331?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2021-04-09. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT04829331?
The interventions under investigation include: Restrata (DEVICE).
Who is sponsoring clinical trial NCT04829331?
This trial is sponsored by Acera Surgical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04829331's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI